Your Source for Venture Capital and Private Equity Financings

VC-funded Company:

Prellis Biologics
c/o IndieBio
479 Jessie Street
San Francisco, CA 94103

Prellis Biologics aims to eliminate the wait list for human organ transplants and speed up development of vital new drug therapies. Using innovations in 3D printing and stem cell development, Prellis can create tissue and organs with the microvascular systems that are critical for supporting viable human tissue. Based in San Francisco, the company's patent-pending technologies use proven methods in biology, physics, and advanced imaging to revolutionize the field of tissue engineering.

Key Contact
Name
Dr. Noelle Mullin
Title
CEO
Funding Events

Date
Amount
Type
Investors
Valuation
09/14/17 $1,800,000 Seed 415 Ventures
Civilization Ventures
True Ventures
undisclosed
08/01/19 $8,700,000 Series A IndieBio
Khosla Ventures
True Ventures
undisclosed